Medi-Fare Drug and Pharmaceutical Compounding, LLC, Blacksburg, SC
Is Medi-Fare Drug and Pharmaceutical Compounding, LLC registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels its entry 503B.
Does Medi-Fare Drug and Pharmaceutical Compounding, LLC hold a South Carolina pharmacy license?
State board of pharmacy records for South Carolina are not checked: the Department of Labor, Licensing and Regulation’s board website did not respond to this index’s requests on November 6, 2026, or when tried again on November 7, 2026.
Has Medi-Fare Drug and Pharmaceutical Compounding, LLC had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 untitled letter (Mar 18, 2019) and 1 FMD-145 letter (Oct 23, 2023) for Medi-Fare Drug and Pharmaceutical Compounding, LLC. State board of pharmacy records for South Carolina are not checked: the Department of Labor, Licensing and Regulation’s board website did not respond to this index’s requests on November 6, 2026, or when tried again on November 7, 2026.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Medi-Fare Drug and Pharmaceutical Compounding, LLC
- Location
- Blacksburg, SC
- Type as FDA labels it
- 503B
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 2
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Jun 6, 2025
- FDA Data Dashboard inspections
- No matching site found
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Medi-Fare Drug and Pharmaceutical Compounding, LLC, a 503B facility, with 4 dated actions.
| Document | |||
|---|---|---|---|
| Jun 6, 2025 | Form 483 | 483 Issued 06/06/2025 | fda.gov |
| Oct 23, 2023 | FMD-145 letter | FMD-145 Letter Issued 10/23/2023 | Not linked by FDA |
| May 26, 2023 | Form 483 | 483 Issued 05/26/2023 | FDA copy (archived) |
| Mar 18, 2019 | Untitled letter | Untitled Letter 03/18/2019 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.
State board of pharmacy records
State board of pharmacy records for South Carolina are not checked: the Department of Labor, Licensing and Regulation’s board website did not respond to this index’s requests on November 6, 2026, or when tried again on November 7, 2026.
This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
Records last pulled Nov 15, 2026. Every entry links to the original public record.